Atlas Trials

CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer

Clinical trial NCT07213206 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07213206
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-10-07
Primary completion
2032-09-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.